No Data
No Data
Wadakohsan: Notice regarding financial results of unlisted parent companies, etc.
Wadakohsan To Go Ex-Dividend On February 27th, 2025 With 39 JPY Dividend Per Share
February 26th (Japan Standard Time) - $Wadakohsan(8931.JP)$ is trading ex-dividend on February 27th, 2025.Shareholders of record on February 28th, 2025 will receive 39 JPY dividend per share. The ex-
Wadakohsan Records 16% Higher Net Income in Nine Months to November
Wada Kousan---3Q increased revenue and double-digit profit growth, with sales of condominium units and QITABANKUAI performing well.
Wada Kousan <8931> announced its financial results for the third quarter of the fiscal year ending February 2025 (March-November 2024) on the 7th. Revenue increased by 4.5% year-on-year to 33.746 billion yen, operating profit increased by 16.0% to 4.66 billion yen, ordinary profit increased by 16.8% to 4.092 billion yen, and quarterly net profit increased by 16.2% to 2.813 billion yen. Revenue from the sale of condominium apartments was 26.144 billion yen, an increase of 2.4% year-on-year, while segment profit (operating profit) increased by 6.8% to 3.741 billion yen.
Volume change rate ranking (9 AM) ~ Wada Kousan, NF HD, etc. have made the ranking.
In the ranking of Volume change rates, comparing the average Volume over the last five days with the Volume on the distribution day provides insights into the trends of market participants' interests, etc. ■Top Volume change rates [As of January 8, 9:32] (Comparison with the average Volume over the last five days) Stock code Stock name Volume 5-day average Volume Volume change rate Stock price change rate <4591> Ribomic 9360600107185.08327.33% 0.1566% <4558> Chukyo Medical
Wada Kousan has ranked, with operating profit for the cumulative third quarter increasing by 16%, reversing the loss from the first half of the year to profit.
Wada Kōsan (8931) is ranked (as of 9:32 AM). It has significantly continued to rise. After the previous day's trading ended, the third-quarter financial results were announced. Cumulative operating profit is 4.66 billion yen (an increase of 16.0% compared to the same period last year). This marks a return to profit growth from the first half's 2.176 billion yen (a decrease of 13.0% year-on-year). The main business of selling condominium units has focused on sales activities aimed at securing contracts, particularly for newly released properties, and promoting handover plans. The operating profit for the fiscal year ending February 2025 is forecasted to be 4.95 billion yen (an increase of 9.3% compared to the previous period). Volume change rate increase.